RF
Highly rated in
18
conditions

Dr. Robert L. Ferris

University Ear, Nose And Throat Specialists
Pittsburgh, PA
Highly rated in
18
conditions
Specialties:Otolaryngology
Experience:27 Years
Clinical Trials:Currently Recruiting for 5 Trials
Accepts:New PatientsMedicare
Highly rated in
18
conditions
About|Expertise|Insurance|Location|Research
Check Dr. Robert L. Ferris experience treating your condition:
About Dr. Robert L. Ferris

Robert Ferris is an Otolaryngologist in Pittsburgh, Pennsylvania. Dr. Ferris has been practicing medicine for over 27 years and is highly rated in 18 conditions, according to our data. His top areas of expertise are Head and Neck Squamous Cell Carcinoma, Human Papillomavirus Infection, Oral Squamous Cell Carcinoma, and Tongue Cancer. He is licensed to treat patients in Pennsylvania. Dr. Ferris is currently accepting new patients.

His clinical research consists of co-authoring 417 peer reviewed articles and participating in 16 clinical trials in the past 15 years.

Areas of Expertise

Many experts have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions aexpert treats and their level of experience.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Robert L. Ferris it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Robert L. Ferris accepts the following insurance:

  •  Ambetter
Call to see if your plan is accepted.
Locations
  5200 Centre Ave, Pittsburgh, PA 15232, US
 412-621-XXXX
Background & Education
Graduate Institution
Kansas City College Of Medicine And Surgery, 1995
Specialties
Otolaryngology
Hospital Affiliations
UPMC Horizon - Greenville
UPMC Presbyterian
UPMC Magee-Womens Hospital
UPMC Mercy
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

15 Clinical Trials
Recruiting
Enrollment Status:Recruiting
Intervention Type:Device
Study Phase: Phase 1/Phase 2
Utilization of Low Level Laser Therapy for Radiation Induced Dermatitis in Patients With Head and Neck Squamous Cell Carcinoma
View Trial
Recruiting
Enrollment Status:Recruiting
Intervention Type:Drug, Other, Radiation
Study Phase: Phase 2
Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
View Trial
Recruiting
Enrollment Status:Recruiting
Intervention Type:Drug, Radiation
Study Phase: Phase 2
Randomized Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated Squamous Cell Carcinoma of the Head and Neck (SCCHN)
View Trial
Recruiting
Enrollment Status:Recruiting
Intervention Type:Drug
Study Phase: Phase 2
A Phase II Neoadjuvant Study of the Safety and Tolerability of Anti-PD1 (Nivolumab) Administered Alone or in Combination With Anti-LAG3 (Relatlimab) or Anti-CTLA4 (Ipilimumab) in Resectable Head and Neck Cancer
View Trial
Recruiting
Enrollment Status:Recruiting
Intervention Type:Radiation, Biological, Drug
Study Phase: Phase 2
Phase II Study Evaluating HPV-16 Vaccination (ISA101b) and Pembrolizumab Plus Cisplatin Chemoradiotherapy for Intermediate Risk HPV-16 Associated Head and Neck Squamous Cell Carcinoma (HNSCC)
View Trial
Enrollment Status:Withdrawn
Intervention Type:Biological
Study Phase: Phase 1
Active Immunization of Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) Using Fibroblasts Transfected With DNA From Autologous Tumor
View Trial
Enrollment Status:Active, not recruiting
Intervention Type:Biological, Other, Radiation
Study Phase: Phase 1
A Phase Ib Trial of Concurrent Cetuximab (ERBITUX®) and Intensity Modulated Radiotherapy (IMRT) With Ipilimumab (YERVOY®) in Locally Advanced Head and Neck Cancer
View Trial
Enrollment Status:Completed
Intervention Type:Radiation, Drug
Study Phase: Phase 2
A Phase II Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer
View Trial
Enrollment Status:Completed
Intervention Type:Biological, Procedure
Study Phase: Phase 1
Adjuvant p53 Peptide Loaded DC-Based Therapy for Subjects With Squamous Cell Cancer of the Head and Neck (A Phase I Safety and Immunogenicity Trial)
View Trial
Enrollment Status:Completed
Intervention Type:Drug
Study Phase: Phase 1
Phase I Trial of Intratumoral Administration of HF10, A Replication Competent Herpes Simplex Virus Type 1, in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
View Trial
Enrollment Status:Active, not recruiting
Intervention Type:Drug, Radiation
Study Phase: Phase 1
Safety Evaluations of Nivolumab (Anti-PD-1) Added To Chemotherapy (CRT) Platforms In Patients With Intermediate And High-Risk Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma
View Trial
Enrollment Status:Active, not recruiting
Intervention Type:Radiation, Drug
Study Phase: Phase 2
Phase II Trial of Adjuvant De-Escalated Radiation + Concurrent and Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer
View Trial
Enrollment Status:Active, not recruiting
Intervention Type:Drug, Procedure, Other, Radiation
Study Phase: Phase 2
Phase II Randomized Trial of Transoral Surgical Resection Followed by Low-Dose or Standard-Dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
View Trial
Enrollment Status:Not yet recruiting
Intervention Type:Procedure, Other, Drug, Radiation
Study Phase: Phase 2
Phase II Trial of Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
View Trial
Enrollment Status:Not yet recruiting
Intervention Type:Drug, Radiation
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled, 2-arm Phase III Study to Assess Efficacy and Safety of Xevinapant and Radiotherapy Compared to Placebo and Radiotherapy for Demonstrating Improvement of Disease-free Survival in Participants With Resected Squamous Cell Carcinoma of the Head and Neck, Who Are at High Risk for Relapse and Are Ineligible for High-dose Cisplatin (XRAY VISION)
View Trial
View 10 Less Clinical Trials -
417 Total Publications
Journal: Journal for immunotherapy of cancer
Published —February 25, 2022
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial.
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
SK
Dr. Seungwon W. Kim
Otolaryngology
Highly rated in
18
conditions
Otolaryngology

University of Pittsburgh Medical Center

University Ear, Nose And Throat Specialists

203 Lothrop St 
Pittsburgh, PA 15213
 1.4 mi

Seungwon Kim is an Otolaryngologist in Pittsburgh, Pennsylvania. Dr. Kim has been practicing medicine for over 24 years and is highly rated in 18 conditions, according to our data. His top areas of expertise are Oral Squamous Cell Carcinoma, Tongue Cancer, Head and Neck Squamous Cell Carcinoma, and Salivary Gland Tumors. He is licensed to treat patients in Pennsylvania. Dr. Kim is currently accepting new patients.

View Profile
CS
Dr. Carl H. Snyderman
Otolaryngology
Highly rated in
12
conditions
Otolaryngology

University of Pittsburgh Medical Center

University Ear, Nose And Throat Specialists

200 Lothrop St 
Pittsburgh, PA 15213
 1.4 mi

Carl Snyderman is an Otolaryngologist in Pittsburgh, Pennsylvania. Dr. Snyderman has been practicing medicine for over 40 years and is highly rated in 12 conditions, according to our data. His top areas of expertise are Olfactory Neuroblastoma, Sinus Cancer, Cerebrospinal Fluid Leak, and Craniopharyngioma. He is licensed to treat patients in Pennsylvania. Dr. Snyderman is currently accepting new patients.

View Profile
SL
Dr. Stella E. Lee
Otolaryngology
Highly rated in
7
conditions
Otolaryngology

University of Pittsburgh Medical Center

Shadyside Medical Building (Joint Reconstruction Center)

5200 Centre Ave 
Pittsburgh, PA 15232
 0.1 mi

Stella Lee is an Otolaryngologist in Pittsburgh, Pennsylvania. Dr. Lee has been practicing medicine for over 17 years and is highly rated in 7 conditions, according to our data. Her top areas of expertise are Chronic Rhinosinusitis with Nasal Polyps, Sinusitis, Nasal Polyps, and Allergic Rhinitis. She is licensed to treat patients in Pennsylvania. Dr. Lee is currently accepting new patients.

View Profile